MedTrace Logo

Metabolomics in Occupational Asthma

NCT04301674 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-08-24

No results posted yet for this study

Summary

The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).

Conditions

  • Asthma, Occupational

Interventions

DEVICE

Breath Biopsy

ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)

Sponsors & Collaborators

  • Owlstone Ltd

    collaborator INDUSTRY

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Bato Hammarstrøm, MD/PhD · Oslo University Hospital

  • Tonje Trulssen Hildre, M.Sc. · Oslo University Hospital

  • Hilde Heiro, MD · Oslo University Hospital

  • Britt G Randem, MD/PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2022-12-31
Completion
2023-06-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04301674 on ClinicalTrials.gov